Quarterly report pursuant to Section 13 or 15(d)

Balance Sheets Details (Tables)

v3.22.2
Balance Sheets Details (Tables)
6 Months Ended
Jun. 30, 2022
Balance Sheets Details [Abstract]  
Schedule of Cash and Cash Equivalents Cash equivalents as of June 30, 2022 and December 31, 2021, consisted of the following (in thousands):
  June 30, 2022 December 31, 2021
  Adjusted Cost Estimated Fair Value Adjusted Cost Estimated Fair Value
Money market funds (1)
$ 67,218  $ 67,218  $ 86,095  $ 86,095 
(1) Money market funds are classified in cash and cash equivalents on our unaudited consolidated balance sheets. Average contractual maturities (in days) is not applicable.
Schedule of Inventory Components Inventories consisted of the following (in thousands):
June 30, 2022 December 31, 2021
Raw materials $ 49  $ 49 
Work-in-process 73  65 
Finished goods 1,596  1,046 
    Inventories $ 1,718  $ 1,160 
Schedule of Property and Equipment, Net
Property and equipment, net consisted of the following (in thousands):
June 30, 2022 December 31, 2021
Laboratory equipment $ 38,378  $ 33,101 
Leasehold improvements 16,609  16,117 
Computer equipment and software 3,836  3,481 
Office equipment and furniture 1,320  1,297 
Construction in progress 1,670  3,231 
Property and equipment 61,813  57,227 
       Less: accumulated depreciation and amortization (38,119) (35,882)
     Property and equipment, net $ 23,694  $ 21,345 
Depreciation expense included in both research and development expenses and selling, general and administrative expenses in the unaudited condensed consolidated statements of operations was as follows (in thousands):
Three Months Ended June 30, Six Months Ended June 30,
2022 2021 2022 2021
Depreciation expense $ 1,341  $ 716  $ 2,556  $ 1,375 
Schedule of Other Accrued Liabilities Other accrued liabilities consisted of the following (in thousands):
June 30, 2022 December 31, 2021
Accrued purchases $ 8,292  $ 6,755 
Accrued professional and outside service fees 4,113  5,147 
Other 529  676 
     Total $ 12,934  $ 12,578